As market access specialists, we help our partners make decisions that deliver patient impact and drive portfolio success. Insight to impact. Knowledge to life.

Who we are

Dolon is an independent consultancy specialising in market access strategy for rare diseases and oncology – areas defined by unique challenges, yet united in complexity.

We help redefine what’s possible for our clients and patients, turning uncertainty into insight so that innovation reaches those who need it, in ways that are sustainable for both industry and society.

Our services

We recognise that achieving access for rare disease and oncology medicines requires us to go further. At Dolon, we help our clients define their payer strategy and shape a positive access environment.

Value

Cutting through the noise to turn complex landscapes and evidence into high-impact value strategies – bridging clinical promise and reimbursement reality.

See More

Access

Guiding our clients through global payer pathways to ensure launch readiness and deliver on their ambition – providing life-changing treatments to those who need them.

See More

Pricing

Helping our clients navigate complexity with confidence to craft a robust and communicable price strategy – credible from the boardroom to the negotiating table.

See More

Market Access Policy

Identifying the access policy imperatives most important to our client's portfolios, and helping them build compelling evidence, credible payer proposals, and stakeholder engagement to drive positive change within existing frameworks.

See More

Data & Analytics

Turning data into decisions that define direction and influence outcomes through our advanced bespoke models, internal databases, and proprietary tools.

See More

Why Dolon?

Specialist

Narrow specialism brings deep expertise – with a decade of experience exclusively in rare diseases and oncology, we are masters of our niche.

Strategic

We were founded on the fundamental principle of strategy first – with this as our north star, we cut through complexity to deliver clarity.

Analytical

We recognise that robust data drives informed decision-making – our insights are underpinned with in-house databases, analytics and tools.

Influential

Dolon have spent years at the forefront of shaping access policy in rare diseases and oncology - we bring thought leadership to help our clients pioneer change.

Collaborative

United by a shared drive for innovation and excellence, we’re proud to forge lasting peer-like partnerships with our clients founded on excellence, fresh perspectives, mutual respect and honesty.

About Us

Learn More

Dolon in numbers

Specialist 

knowledge

97%

Projects delivered in 

rare diseases and oncology

Extensive
experience

12+

Years delivering
access success

Global 

perspective

95%

Projects with global
or multi-region scope

Proven 

track record

1000+

Successful
engagements

What our clients think

Dolon is one of the most customer centric partners. 
They are extremely agile, flexible and adapt to all situations which creates a very fluid and smooth collaboration.

Senior Director, Value & Access

Dolon is a top-tier agency that feels like part of our family. Dolon’s bespoke, strategic approach and true partnership mindset set it apart from cookie-cutter solutions.

Global Pricing & Access Strategy Lead

I’ve had several engagements with the team(s) at Dolon over the last few years. I’ve been consistently impressed by two things - thought partnership and depth / precision of the deliverables. When we have complex hurdles that need insight development, I will continue to pursue the ability to work with this agency; they are exceptional

Senior Director, Global Pricing & Analytics

Dolon has been an excellent strategic partner - they challenge our thinking and come to us with well thought out proposals to improve our value proposition.

Executive Director, Value & Access

Looking for a strategic partner? Start a conversation.